Clinical Trials Directory

Trials / Unknown

UnknownNCT04415346

A Single Center, Phase I Clinical Trial to Evaluate the Safety of LIZTOX Inj in the Treatment of Post Stroke Upper Limb Spasticity

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
13 (actual)
Sponsor
Huons Co., Ltd. · Industry
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

* Investigational Product: LIZTOX inj 100unit(HU-014) * Title : A Single Center, Phase I Clinical Trial to Evaluate the Safety of LIZTOX Inj in the Treatment of Post Stroke Upper Limb Spasticity * Sites and investigators : Asan Medical Center(Seoul), Min-ho Chun, M.D, Ph.D * Objective : To evaluate the safety of LIZTOX inj in the treatment of Post Stroke Upper Limb Spasticity

Conditions

Interventions

TypeNameDescription
BIOLOGICALHU-014 InjClostridium botulinum type A

Timeline

Start date
2019-11-06
Primary completion
2020-06-01
Completion
2020-10-01
First posted
2020-06-04
Last updated
2020-06-04

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT04415346. Inclusion in this directory is not an endorsement.